Community Health Systems Inc Stock Upgraded (CYH)
NEW YORK (TheStreet) -- Community Health Systems (NYSE:CYH) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
- The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Health Care Providers & Services industry average. The net income increased by 23.1% when compared to the same quarter one year prior, going from $61.32 million to $75.47 million.
- Despite its growing revenue, the company underperformed as compared with the industry average of 13.1%. Since the same quarter one year prior, revenues rose by 10.4%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
- The stock has not only risen over the past year, it has done so at a faster pace than the S&P 500, reflecting the earnings growth and other positive factors similar to those we have cited here. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
- COMMUNITY HEALTH SYSTEMS INC's earnings per share improvement from the most recent quarter was slightly positive. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, COMMUNITY HEALTH SYSTEMS INC reported lower earnings of $2.86 versus $3.09 in the prior year. This year, the market expects an improvement in earnings ($3.64 versus $2.86).
-- Written by a member of TheStreet Ratings Staff
TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
Latest Headlines about CYH
-
5 Names Seeing Bullish Flow
11:23AM 06/06/13
-
Analysts' Actions: BAC CAT CYH WU YUM
08:46AM 04/23/13
-
NYSE Stocks Posting Largest Percentage Increases
06:04PM 11/07/12
-
NYSE Stocks Posting Largest Percentage Increases
01:15PM 11/07/12
-
Community Health Systems Management Discusses Q2 2012 Results - Earnings Call Transcript
05:40PM 07/26/12
-
Upgrades Roundup: PulteGroup, Meredith
05:57AM 07/09/12
-
TheStreet Ratings Top 10 Rating Changes
12:52PM 07/02/12
Latest from TheStreet Wire
-
Abbott Laboratories (ABT): Today's Featured Health Services Laggard
05:22PM 06/19/13
-
Petroleo Brasileiro SA Petrobras (PBR): Today's Featured Basic Materials Laggard
05:01PM 06/19/13
-
Microsoft Corporation (MSFT): Today's Featured Computer Software & Services Laggard
05:01PM 06/19/13
-
Target Corp (TGT): Today's Featured Services Laggard
05:01PM 06/19/13
-
Teck Resources Ltd (TCK): Today's Featured Metals & Mining Laggard
05:01PM 06/19/13
-
United Technologies Corp (UTX): Today's Featured Industrial Laggard
05:01PM 06/19/13
-
Texas Instruments Inc. (TXN): Today's Featured Electronics Laggard
05:01PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
